Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 407
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05971108 | Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC | ||
| NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | ||
| NCT02822547 | Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults | ||
| NCT00193609 | Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site | ||
| NCT00275548 | Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C | ||
| NCT01167049 | Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis | ||
| NCT04641676 | A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center | ||
| NCT03721484 | CINtec PLUS Triage in HPV Primary Screening | ||
| NCT01249638 | Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC | ||
| NCT03192215 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | ||
| NCT02575157 | Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates | ||
| NCT00050167 | Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | ||
| NCT04161248 | Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma | ||
| NCT04462276 | Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease | ||
| NCT01583426 | Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) | ||
| NCT01847677 | Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin | ||
| NCT01828736 | Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma | ||
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer | ||
| NCT02987400 | Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL | ||
| NCT03275311 | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | ||
| NCT01259817 | Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) | ||
| NCT00100659 | PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C | ||
| NCT01640405 | Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells | ||
| NCT04993274 | Sensitivity of Motor Assessment in MS - a Prospective Cohort Study | ||
| NCT03229382 | Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse | ||
| NCT02383290 | The Implementation of Pharmacogenomics Into Primary Care in British Columbia | ||
| NCT01101295 | The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. | ||
| NCT02739594 | Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma | ||
| NCT01329952 | Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment | ||
| NCT00273767 | Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB | ||
| NCT00166712 | A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression | ||
| NCT05975242 | Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes | ||
| NCT01456312 | HBsAg Related Response Guided Therapy | ||
| NCT00457301 | Using Health-related Quality of Life (HRQL) in Routine Clinical Care | ||
| NCT02389283 | Reduced Ultrasound Counts in Rheumatoid Arthritis | ||
| NCT02060669 | Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer | ||
| NCT03474094 | Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy | ||
| NCT02003703 | Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . | ||
| NCT02499003 | GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma | ||
| NCT03721653 | FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients | ||
| NCT01185223 | Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation | ||
| NCT05283213 | Development of an Innovative Clinico-biological Score for the Early Detection of Acute Renal Failure Associated With Cardiac Surgery. | ||
| NCT05075538 | COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 | ||
| NCT07387848 | Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas | ||
| NCT00264290 | Valganciclovir to Reduce T Cell Activation in HIV Infection | ||
| NCT01790633 | Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests | ||
| NCT00262717 | Can Resistance Enhance Selection of Treatment? (CREST) | ||
| NCT02064491 | Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC | ||
| NCT02738580 | Follicular Steroid Genesis in Controlled Ovarian Stimulation | ||
| NCT01660776 | BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology |
